<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"
            xmlns:fmx="http://formex.publications.europa.eu/schema/formex-05.21-20110601.xd"
            xmlns:leos="urn:eu:europa:ec:leos"
            xmlns:xs="http://www.w3.org/2001/XMLSchema">
   <bill name="">
      <meta xmlns:fn="http://www.w3.org/2005/xpath-functions">
         <identification source="~COM">
            <FRBRWork>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
               <FRBRcountry value=""/>
            </FRBRWork>
            <FRBRExpression>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
               <FRBRlanguage language="eng"/>
            </FRBRExpression>
            <FRBRManifestation>
               <FRBRthis value=""/>
               <FRBRuri value=""/>
               <FRBRdate date="2999-01-01" name=""/>
               <FRBRauthor href=""/>
            </FRBRManifestation>
         </identification>
      </meta>
      <preface>
         <longTitle>
            <p>
               <docStage/>
               <docType>COMMISSION REGULATION (EU) 2017/1203</docType>of 5 July 2017<docPurpose>amending Directive 2002/46/EC of the European Parliament and of the Council and Regulation (EC) No 1925/2006 of the European Parliament and of the Council as regards organic silicon (monomethylsilanetriol) and calcium phosphoryl oligosaccharides (POs-Ca®) added to foods and used in the manufacture of food supplements</docPurpose>
            </p>
         </longTitle>
         <container name="EEArelevance">
            <p>(Text with EEA relevance)</p>
         </container>
      </preface>
      <preamble>
         <formula name="actingEntity">
            <p>THE EUROPEAN COMMISSION,</p>
         </formula>
         <citations>
            <citation>
               <p>Having regard to the Treaty on the Functioning of the European Union,</p>
            </citation>
            <citation>
               <p>Having regard to Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of the Member States relating to food supplements<authorialNote placement="bottom" marker="1">
                     <p>OJ L 183, 12.7.2002, p. 51.</p>
                  </authorialNote>, and in particular Article 4(5) thereof,</p>
            </citation>
            <citation>
               <p>Having regard to Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of vitamins and minerals and of certain other substances to foods<authorialNote placement="bottom" marker="2">
                     <p>OJ L 404, 30.12.2006, p. 26.</p>
                  </authorialNote>, and in particular Article 3(3) thereof,</p>
            </citation>
         </citations>
         <recitals xml:id="recs_d140e82">
            <intro>
               <p>Whereas:</p>
            </intro>
            <recital xml:id="rec_d140e85">
               <num>(1)</num>
               <p>Annex II to Directive 2002/46/EC establishes the list of vitamin and mineral substances, which may be used in the manufacture of food supplements.</p>
            </recital>
            <recital xml:id="rec_d140e91">
               <num>(2)</num>
               <p>According to Article 14 of Directive 2002/46/EC, provisions on vitamin and mineral substances in food supplements which may have an effect upon public health are to be adopted after consultation with the European Food Safety Authority (&apos;the Authority&apos;).</p>
            </recital>
            <recital xml:id="rec_d140e101">
               <num>(3)</num>
               <p>Annex II to Regulation (EC) No 1925/2006 establishes the list of vitamin and mineral substances, and for each of them the forms, which may be added to foods.</p>
            </recital>
            <recital xml:id="rec_d140e107">
               <num>(4)</num>
               <p>According to Article 3(3) of Regulation (EC) No 1925/2006, modifications to the list provided in Annex II to that Regulation are to be adopted taking account of the opinion of the Authority.</p>
            </recital>
            <recital xml:id="rec_d140e113">
               <num>(5)</num>
               <p>Following a request for the addition of organic silicon as a source of silicon to the list set out in Annex II to Directive 2002/46/EC, on 9 March 2016 the Authority adopted a Scientific Opinion on the safety of organic silicon (monomethylsilanetriol; MMST) as a novel food ingredient for use as a source of silicon in food supplements and bioavailability of orthosilicic acid from the source<authorialNote placement="bottom" marker="3">
                     <p>
                        <i>EFSA Journal</i> 2016;14(4):4436</p>
                  </authorialNote>.</p>
            </recital>
            <recital xml:id="rec_d140e128">
               <num>(6)</num>
               <p>It follows from that opinion that the use of organic silicon (monomethylsilanetriol) in food supplements is not of a safety concern as a source of silicon, provided that certain conditions are respected.</p>
            </recital>
            <recital xml:id="rec_d140e134">
               <num>(7)</num>
               <p>Taking into account the Authority&apos;s favourable opinion, organic silicon (monomethylsilanetriol) should be included in the list set out in Annex II to Directive 2002/46/EC.</p>
            </recital>
            <recital xml:id="rec_d140e140">
               <num>(8)</num>
               <p>Following a request for the addition of calcium phosphoryl oligosaccharides (POs-Ca®) as a source of calcium to the list set out in Annex II to Directive 2002/46/EC and to the list set out in Annex II to Regulation (EC) No 1925/2006, on 26 April 2016 the Authority adopted a Scientific Opinion on the safety of calcium phosphoryl oligosaccharides (POs-Ca®) as a source of calcium added for nutritional purposes to food, food supplements and foods for special medical purposes<authorialNote placement="bottom" marker="4">
                     <p>
                        <i>EFSA Journal</i> 2016;14(6):4488</p>
                  </authorialNote>.</p>
            </recital>
            <recital xml:id="rec_d140e155">
               <num>(9)</num>
               <p>It follows from that opinion that the addition of calcium phosphoryl oligosaccharides (POs-Ca®) to food and its use in food supplements is not of a safety concern as a source of calcium, provided that certain conditions are respected.</p>
            </recital>
            <recital xml:id="rec_d140e163">
               <num>(10)</num>
               <p>Taking into account the Authority&apos;s favourable opinion, calcium phosphoryl oligosaccharides (POs-Ca®) should be included in the list set out in Annex II to Directive 2002/46/EC and in the list set out in Annex II to Regulation (EC) No 1925/2006.</p>
            </recital>
            <recital xml:id="rec_d140e169">
               <num>(11)</num>
               <p>Interested parties were consulted through the Advisory Group on the Food Chain and Animal and Plant Health and the comments provided were taken into consideration.</p>
            </recital>
            <recital xml:id="rec_d140e175">
               <num>(12)</num>
               <p>Directive 2002/46/EC and Regulation (EC) No 1925/2006 should therefore be amended accordingly.</p>
            </recital>
            <recital xml:id="rec_d140e181">
               <num>(13)</num>
               <p>The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,</p>
            </recital>
         </recitals>
         <formula name="enactingFormula">
            <p>HAS ADOPTED THIS REGULATION:</p>
         </formula>
      </preamble>
      <body>
         <article xml:id="art_d140e190">
            <num>Article 1</num>
            <heading/>
            <paragraph>
               <content>
                  <p>Annex II to Directive 2002/46/EC is amended in accordance with the Annex to this Regulation.</p>
               </content>
            </paragraph>
         </article>
         <article xml:id="art_d140e195">
            <num>Article 2</num>
            <heading/>
            <paragraph>
               <content>
                  <p>Annex II to Regulation (EC) No 1925/2006 is amended in accordance with the Annex to this Regulation.</p>
               </content>
            </paragraph>
         </article>
         <article xml:id="art_d140e200">
            <num>Article 3</num>
            <heading/>
            <paragraph>
               <content>
                  <p>This Regulation shall enter into force on the twentieth day following that of its publication in the <i>Official Journal of the European Union</i>.</p>
               </content>
            </paragraph>
         </article>
         <clause>
            <content>
               <p>This Regulation shall be binding in its entirety and directly applicable in all Member States.</p>
            </content>
         </clause>
      </body>
      <conclusions>
         <p>Done at Brussels, 5 July 2017.</p>
         <block name="signatory">
            <signature>
               <organization refersTo="">For the Commission</organization>
               <role refersTo="">The President</role>
               <person refersTo="">Jean-Claude JUNCKER</person>
            </signature>
         </block>
      </conclusions>
   </bill>
</akomaNtoso>
